Research ArticleArticle
Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort
Gaël Mouterde, Etienne Gamon, Nathalie Rincheval, Cédric Lukas, Raphaele Seror, Francis Berenbaum, Anne-Marie Dupuy, Claire Daien, Jean-Pierre Daurès and Bernard Combe
The Journal of Rheumatology December 2019, jrheum.190795; DOI: https://doi.org/10.3899/jrheum.190795
Gaël Mouterde
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Etienne Gamon
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Nathalie Rincheval
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Cédric Lukas
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Raphaele Seror
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Francis Berenbaum
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Anne-Marie Dupuy
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Claire Daien
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Jean-Pierre Daurès
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
Bernard Combe
An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study. G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France. Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr. Accepted for publication December 6, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort
Gaël Mouterde, Etienne Gamon, Nathalie Rincheval, Cédric Lukas, Raphaele Seror, Francis Berenbaum, Anne-Marie Dupuy, Claire Daien, Jean-Pierre Daurès, Bernard Combe
The Journal of Rheumatology Dec 2019, jrheum.190795; DOI: 10.3899/jrheum.190795
Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort
Gaël Mouterde, Etienne Gamon, Nathalie Rincheval, Cédric Lukas, Raphaele Seror, Francis Berenbaum, Anne-Marie Dupuy, Claire Daien, Jean-Pierre Daurès, Bernard Combe
The Journal of Rheumatology Dec 2019, jrheum.190795; DOI: 10.3899/jrheum.190795